Formulation Characterisation & Development
Research scientists at i2c have extensive development experience across a range of inhalation products including pMDIs, DPIs, small volume liquid inhalers and nebulisers. We provide a responsive, client-centric service. Our research facilities enable us to rapidly characterise, refine and optimise formulations and to conduct stability studies under standard ICH conditions. In conjunction with Simbec-Orion, i2c’s broad service offering extends to supporting clinical development programs.
Formulation development support functions include:
- Aerosol particle sizing and inhaler performance characterisation
- Dose uniformity and potency tests
- Disintegration & dissolution testing of oral dosage forms
- Powder characterisation
- Analytical methods development and optimisation
- Moisture content
- Accelerated stability testing
What We Do
Formulation: Characterisation
& Development
Small Scale Manufacture
& Testing
Clinical Gamma
Scintigraphy